应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。
关闭
ABBV 艾伯维公司
休市中 07-24 16:00:00 EDT
259.36
+2.44
+0.95%
盘后
258.05
-1.31
-0.51%
19:58 EDT
最高
260.22
最低
256.77
成交量
419.54万
今开
258.54
昨收
256.92
日振幅
1.34%
总市值
4,584亿
流通市值
4,572亿
总股本
17.67亿
成交额
10.87亿
换手率
0.24%
流通股本
17.63亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
资讯
新帖
简况
财报前瞻｜艾伯维公司本季营收预计增11.54%，机构观点偏乐观
财报Agent · 07-24 08:03
财报前瞻｜艾伯维公司本季营收预计增11.54%，机构观点偏乐观
Genmab与艾伯维就Epcoritamab（Duobody®-CD3xCD20）治疗复发/难治性弥漫大B细胞淋巴瘤的3期EPCORE® DLBCL-1试验作出澄清
美股速递 · 07-24 04:01
Genmab与艾伯维就Epcoritamab（Duobody®-CD3xCD20）治疗复发/难治性弥漫大B细胞淋巴瘤的3期EPCORE® DLBCL-1试验作出澄清
Genmab澄清：总生存期（OS）作为美国3期Epcore® DLBCL-1试验的唯一主要终点，但未能达到
美股速递 · 07-24 04:01
Genmab澄清：总生存期（OS）作为美国3期Epcore® DLBCL-1试验的唯一主要终点，但未能达到
异动解读｜艾伯维公司盘中上涨3.01%，多家投行密集上调目标价
行情直击 · 07-16
异动解读｜艾伯维公司盘中上涨3.01%，多家投行密集上调目标价
Skinmedica® 持续投资研发，深化在再生科学领域的承诺
美股速递 · 07-14
Skinmedica® 持续投资研发，深化在再生科学领域的承诺
艾伯维公司2026年第二季度计入2.91亿美元购买IPR&D费用，影响GAAP及调整后稀释每股收益0.17美元——SEC文件披露
美股速递 · 07-07
艾伯维公司2026年第二季度计入2.91亿美元购买IPR&D费用，影响GAAP及调整后稀释每股收益0.17美元——SEC文件披露
艾伯维宣布Tepkinly®（epcoritamab）联合来那度胺和利妥昔单抗获欧盟委员会批准用于治疗复发或难治性滤泡性淋巴瘤
美股速递 · 07-07
艾伯维宣布Tepkinly®（epcoritamab）联合来那度胺和利妥昔单抗获欧盟委员会批准用于治疗复发或难治性滤泡性淋巴瘤
Genmab宣布Epcoritamab联合来那度胺三期试验取得积极成果
投资观察 · 07-06
Genmab宣布Epcoritamab联合来那度胺三期试验取得积极成果
异动解读｜艾伯维公司盘中上涨3.01%，多项产品获批及积极临床数据持续催化
行情直击 · 07-02
异动解读｜艾伯维公司盘中上涨3.01%，多项产品获批及积极临床数据持续催化
美国众议院委员会就中国药物临床试验展开调查后，默沙东、艾伯维股价盘前下跌。默克股价下跌1.2%，艾伯维股价下跌1%。
智通财经 · 06-30
美国众议院委员会就中国药物临床试验展开调查后，默沙东、艾伯维股价盘前下跌。默克股价下跌1.2%，艾伯维股价下跌1%。
独家：美国议员发函要求获取近十年数百项试验文件，含数据保护流程
美股速递 · 06-30
独家：美国议员发函要求获取近十年数百项试验文件，含数据保护流程
艾伯维宣布Epcoritamab联合来那度胺在复发或难治性弥漫性大B细胞淋巴瘤患者中取得积极三期试验结果
美股速递 · 06-30
艾伯维宣布Epcoritamab联合来那度胺在复发或难治性弥漫性大B细胞淋巴瘤患者中取得积极三期试验结果
艾伯维公司Rinvoq®获欧盟CHMP积极意见 用于治疗成人和青少年非节段型白癜风
美股速递 · 06-29
艾伯维公司Rinvoq®获欧盟CHMP积极意见 用于治疗成人和青少年非节段型白癜风
一周美股牛榜 | Bio-Techne上周飙涨逾22%，艾伯维公司劲升逾17%，联合大陆航空涨超15%，康宁涨超13%
老虎资讯综合 · 06-29
一周美股牛榜 | Bio-Techne上周飙涨逾22%，艾伯维公司劲升逾17%，联合大陆航空涨超15%，康宁涨超13%
异动解读｜艾伯维公司盘中上涨3.31%，109亿美元收购Apogee叠加多重产品获批持续提振
行情直击 · 06-27
异动解读｜艾伯维公司盘中上涨3.31%，109亿美元收购Apogee叠加多重产品获批持续提振
异动解读｜艾伯维公司盘中上涨3.23%，109亿美元收购Apogee持续提振叠加多重利好
行情直击 · 06-25
异动解读｜艾伯维公司盘中上涨3.23%，109亿美元收购Apogee持续提振叠加多重利好
医美巨头证实“司美格鲁肽脸”真实存在 新上市再生医美公司欲入局分羹
美股速递 · 06-25
医美巨头证实“司美格鲁肽脸”真实存在 新上市再生医美公司欲入局分羹
艾伯维-爱力根美学部门将启动培训，为未来数月内Boey的商业上市做准备
美股速递 · 06-23
艾伯维-爱力根美学部门将启动培训，为未来数月内Boey的商业上市做准备
艾伯维宣布Maviret®获欧盟批准用于治疗急性丙型肝炎病毒感染
美股速递 · 06-23
艾伯维宣布Maviret®获欧盟批准用于治疗急性丙型肝炎病毒感染
艾伯维(ABBV)免疫产品SKYRIZI获欧盟批准 扩展至儿童与青少年中重度斑块状银屑病范畴
金吾财讯 · 06-23
艾伯维(ABBV)免疫产品SKYRIZI获欧盟批准 扩展至儿童与青少年中重度斑块状银屑病范畴
公司概况
公司名称：
艾伯维公司
所属市场：
NYSE
上市日期：
--
主营业务：
艾伯维公司注册成立于2012年4月10日，是一家全球性的、以研究为基础的生物制药公司。Abbvie公司从事开发和销售先进的疗法，来解决一些世界上最复杂和严重的疾病。Abbvie公司的产品主要集中在慢性自身免疫性疾病领域，包括类风湿性关节炎，牛皮癣和克罗恩病，银屑病和克罗恩病;低睾酮，HIV，子宫内膜异位症;甲状腺疾病;帕金森病;和并发症的慢性肾脏疾病和囊性纤维化相关的或其他健康问题。
发行价格：
--
{"stockData":{"symbol":"ABBV","market":"US","secType":"STK","nameCN":"艾伯维公司","latestPrice":259.36,"timestamp":1784923200000,"preClose":256.92,"halted":0,"volume":4195437,"hourTrading":{"tag":"盘后","latestPrice":258.05,"preClose":259.36,"latestTime":"19:58 EDT","volume":263789,"amount":68415792.1182,"timestamp":1784937538408,"change":-1.31,"changeRate":-0.005051,"amplitude":0.005051},"delay":0,"changeRate":0.009497119725984732,"floatShares":1762950764,"shares":1767384632,"eps":2.030053,"marketStatus":"休市中","change":2.44,"latestTime":"07-24 16:00:00 EDT","open":258.54,"high":260.22,"low":256.765,"amount":1086921093.5514,"amplitude":0.013448,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":2.030053,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1785139200000},"marketStatusCode":7,"adr":0,"adrRate":0,"exchange":"NYSE","adjPreClose":256.92,"dividendRate":0.025987,"preHourTrading":{"tag":"盘前","latestPrice":257.21,"preClose":256.92,"latestTime":"09:29 EDT","volume":3111,"amount":800937.6207300001,"timestamp":1784899796066,"change":0.29,"changeRate":0.001129,"amplitude":0.007704},"postHourTrading":{"tag":"盘后","latestPrice":258.05,"preClose":259.36,"latestTime":"19:58 EDT","volume":263789,"amount":68415792.1182,"timestamp":1784937538408,"change":-1.31,"changeRate":-0.005051,"amplitude":0.005051},"volumeRatio":0.8193892816510814,"impliedVol":0.3254,"impliedVolPercentile":0.8287},"requestUrl":"/m/hq/s/ABBV/wiki","defaultTab":"wiki","newsList":[{"id":"1175995036","title":"财报前瞻｜艾伯维公司本季营收预计增11.54%，机构观点偏乐观","url":"https://stock-news.laohu8.com/highlight/detail?id=1175995036","media":"财报Agent","labels":["earningPreview"],"top":1,"itemType":null,"share":"https://www.laohu8.com/m/news/1175995036?lang=zh_cn&edition=full","pubTime":"2026-07-24 08:03","pubTimestamp":1784851398,"startTime":"0","endTime":"0","summary":"艾伯维公司将于2026年07月31日发布最新季度财报，市场聚焦免疫与神经科核心产品节奏及利润率修复路径。市场一致预期本季度艾伯维公司营收为167.60亿美元，同比增长11.54%；调整后每股收益为3.60美元，同比增长24.84%；息税前利润为81.44亿美元，同比增长23.40%。上季度公司营收150.02亿美元，同比增长12.43%；毛利率71.88%；归属于母公司股东的净利润为6.95亿美元，净利率4.63%；调整后每股收益为2.65美元，同比增长7.72%。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"财报前瞻｜艾伯维公司本季营收预计增11.54%，机构观点偏乐观","news_tag":"earningPreview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ABBV"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"1135293473","title":"Genmab与艾伯维就Epcoritamab（Duobody®-CD3xCD20）治疗复发/难治性弥漫大B细胞淋巴瘤的3期EPCORE® DLBCL-1试验作出澄清","url":"https://stock-news.laohu8.com/highlight/detail?id=1135293473","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1135293473?lang=zh_cn&edition=full","pubTime":"2026-07-24 04:01","pubTimestamp":1784836901,"startTime":"0","endTime":"0","summary":"Genmab与艾伯维公司（AbbVie）日前就备受关注的3期EPCORE® DLBCL-1临床试验发布了最新澄清说明。该试验旨在全面评估Epcoritamab（Duobody®-CD3xCD20）这一创新疗法在复发或难治性弥漫大B细胞淋巴瘤（DLBCL）患者中的疗效与安全性。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0128525929.USD","LU0203345920.USD","BK4588","IE00B19Z3581.USD","IE00BLSP4239.USD","LU0823416689.USD","LU1244550494.USD","IE00B2B36J28.USD","LU2237443549.SGD","BK4585","LU0868494617.USD","LU1057294990.SGD","LU0417517546.SGD","LU0069063385.USD","LU1162221912.USD","LU0029864427.USD","LU1267930490.SGD","LU1585245621.USD","LU2089284900.SGD","LU1732800096.USD","ABBV","LU1267930573.SGD","LU2347655156.SGD","LU1496350502.SGD","LU0472753341.HKD","LU2237443622.USD","PPH","IE00B42XCP33.USD","LU0965509010.AUD","LU0820561818.USD","IE000BZT7R73.USD","LU0868494708.USD","LU1929549753.HKD","LU0170899867.USD","SG9999015945.SGD","LU0158827948.USD","LU1074936037.SGD","LU1670627923.USD","IE0004445239.USD","LU0114720955.EUR","IE00BJJMRZ35.SGD","LU1989772840.SGD","TRUH","LU1496350171.SGD","IE00BGHQF631.EUR","AGNG","LU0965509283.SGD","MEDX","XLV","LU0511384066.AUD","LU1244550577.SGD","SG9999001440.SGD","IE0000B7K699.USD","IE0002270589.USD","SG9999015978.USD","IE000F7OJYX1.SGD","LU0310799852.SGD","LU0310800379.SGD","LU1093756168.USD","LU0965508806.USD","LU0456855351.SGD","LU0861579265.USD","LU0708994859.HKD","IE000WAW04H5.SGD","LU2237443978.SGD","SG9999015986.USD","VHT","SG9999015952.SGD","LU2129689431.USD","LU0211327993.USD","LU1093756325.SGD","BK4550","IXJ","LU0289739699.SGD","LU2112291526.USD","IE00B4R5TH58.HKD","LU2087621335.USD","LU1244550221.USD","LU0689626769.HKD","LU1732799900.SGD","IE000SO60NU8.SGD","IE00BDGV0183.EUR","LU2133065610.SGD","LU1923622614.USD","IE00B19Z3B42.SGD","JDOC","IE00BVYPNV92.GBP","LU0689472784.USD","LU0211328371.USD","LU1023059063.AUD","LU2125909593.SGD","LU2023251221.USD","LU0289961442.SGD","LU1430594728.SGD","IE00BN8TJ469.HKD","BK4581","LU2129689514.USD","LU1934455863.HKD","LU0256863902.USD","LU0795875169.SGD","LU2357627491.SGD","BK4559","LU0795875086.SGD","BK4566","LU1934455194.USD","LU0234570918.USD","LU0234572021.USD","SG9999011175.SGD","LU2089283258.USD","LU2433249047.HKD","GLAM","SG9999003800.SGD","LU0882574055.USD","IE00BJT1NW94.SGD","IE00B3PB1722.GBP","LU0949170772.SGD","LU0432979614.USD","LU1037948897.HKD","FTXH","LU1551013425.SGD","LU1670628061.USD","LU1839511570.USD","LU1934455277.USD","IE00BLSP4452.SGD","BK4139","LU0912757837.SGD","IE00BVYPNW00.USD","BK4534","LU0965509101.SGD","RXL","IE00BSNM7G36.USD","LU0943347566.SGD","LU1989772923.USD","LU0122379950.USD","LU0553294199.USD","LU0985320562.USD","LU0859254822.USD","LU0057025933.USD","LU1003077747.HKD","LU2129689605.HKD","LU2237443465.HKD","LU0289739343.SGD","IE0002141913.USD","LU1718418525.SGD","LU0256863811.USD","LU1551013342.USD","LU2089984988.USD","IE000MB6IJN5.SGD","LU0320765646.SGD","LU0098860793.USD","LU1061106388.HKD","LU2237443895.HKD","LU2237443382.USD","LU2468319806.SGD","LU1037948541.HKD","LU1291159041.SGD","IYH","FHLC","LU1983299246.USD","LU0198837287.USD","LU0942090050.USD","BK4533","LU0661504455.SGD","LU0820561909.HKD","LU0203347892.USD","LU1989771016.USD","LU0738911758.USD","LU0545039389.USD","LU2125909247.SGD","IE00BBT3K403.USD","IE0009355771.USD","PJP","IE00BFTCPJ56.SGD","LU0124676726.USD","LU0058720904.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1116716506","title":"Genmab澄清：总生存期（OS）作为美国3期Epcore® DLBCL-1试验的唯一主要终点，但未能达到","url":"https://stock-news.laohu8.com/highlight/detail?id=1116716506","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1116716506?lang=zh_cn&edition=full","pubTime":"2026-07-24 04:01","pubTimestamp":1784836871,"startTime":"0","endTime":"0","summary":"Genmab公司近日发布声明，对关于其3期Epcore® DLBCL-1临床试验的结果进行了进一步澄清。该公司明确指出，总生存期（OS）是此项试验在美国设定的唯一主要终点。然而，令人遗憾的是，这一关键终点最终并未能成功达到。\n此声明旨在厘清外界对试验数据的理解，避免不必要的误读。总生存期作为衡量患者从治疗开始到死亡时间的最直接指标，其未达到预期结果，对Genmab而言无疑是一个重大挫折。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1061106388.HKD","LU1093756325.SGD","LU1923622614.USD","IE00BDGV0183.EUR","IE000SO60NU8.SGD","LU1934455863.HKD","LU2129689514.USD","LU0114720955.EUR","BK4139","LU2112291526.USD","LU2125909247.SGD","LU0256863902.USD","IE00BVYPNV92.GBP","LU1670628061.USD","SG9999015978.USD","LU0320765646.SGD","LU1023059063.AUD","LU0124676726.USD","IE00B2B36J28.USD","SG9999015945.SGD","LU0170899867.USD","LU0417517546.SGD","LU0943347566.SGD","RXL","MEDX","LU0965508806.USD","BK4550","LU2433249047.HKD","LU1037948897.HKD","LU0432979614.USD","LU2237443978.SGD","ABBV","LU0289739699.SGD","LU0234570918.USD","BK4585","SG9999015986.USD","LU1244550494.USD","XLV","LU1093756168.USD","IE00B42XCP33.USD","LU0965509283.SGD","LU1934455194.USD","LU0198837287.USD","LU0820561818.USD","LU1585245621.USD","LU0868494617.USD","IE00BLSP4452.SGD","IE000MB6IJN5.SGD","LU0912757837.SGD","LU0456855351.SGD","LU0708994859.HKD","VHT","IE00B4R5TH58.HKD","LU0795875086.SGD","LU1929549753.HKD","LU1983299246.USD","LU1989771016.USD","LU1934455277.USD","SG9999011175.SGD","IE00BJT1NW94.SGD","LU1551013342.USD","TRUH","LU0738911758.USD","IE00BBT3K403.USD","LU0289739343.SGD","LU0256863811.USD","LU0689626769.HKD","IE0004445239.USD","LU1989772840.SGD","LU0795875169.SGD","LU0985320562.USD","BK4566","IE00B19Z3581.USD","LU2023251221.USD","IE0002270589.USD","LU0122379950.USD","SG9999003800.SGD","LU2237443549.SGD","LU0868494708.USD","LU1496350502.SGD","IE0009355771.USD","IE00BSNM7G36.USD","LU1551013425.SGD","LU2468319806.SGD","IE00BLSP4239.USD","LU0234572021.USD","LU1718418525.SGD","LU1003077747.HKD","LU0310800379.SGD","BK4588","LU0965509101.SGD","SG9999001440.SGD","LU2237443622.USD","LU0310799852.SGD","LU0965509010.AUD","AGNG","LU0949170772.SGD","LU0211327993.USD","PPH","LU2237443382.USD","LU1267930490.SGD","LU0859254822.USD","LU1037948541.HKD","LU2357627491.SGD","IE00B19Z3B42.SGD","IE0000B7K699.USD","LU2237443465.HKD","IE000F7OJYX1.SGD","LU2347655156.SGD","LU0203345920.USD","LU0203347892.USD","IE00B3PB1722.GBP","IE00BN8TJ469.HKD","JDOC","LU0553294199.USD","IE000BZT7R73.USD","LU0882574055.USD","LU1162221912.USD","IE00BJJMRZ35.SGD","LU0820561909.HKD","LU2237443895.HKD","LU1496350171.SGD","IYH","LU0511384066.AUD","LU2129689431.USD","IE00BFTCPJ56.SGD","LU1430594728.SGD","LU2129689605.HKD","BK4581","LU0211328371.USD","LU0029864427.USD","LU2087621335.USD","PJP","LU2089283258.USD","LU1074936037.SGD","LU0289961442.SGD","BK4559","LU1989772923.USD","LU0661504455.SGD","LU2133065610.SGD","LU0058720904.USD","BK4533","LU0069063385.USD","LU0158827948.USD","LU1839511570.USD","LU0689472784.USD","LU0861579265.USD","FTXH","LU0128525929.USD","FHLC","IE00BGHQF631.EUR","IXJ","LU0057025933.USD","LU1732800096.USD","LU0823416689.USD","LU0942090050.USD","LU2089284900.SGD","LU2089984988.USD","SG9999015952.SGD","GLAM","LU2125909593.SGD","LU1244550577.SGD","IE0002141913.USD","LU0472753341.HKD","LU1291159041.SGD","LU1670627923.USD","LU0545039389.USD","LU1267930573.SGD","LU1057294990.SGD","LU1244550221.USD","IE000WAW04H5.SGD","LU1732799900.SGD","BK4534","IE00BVYPNW00.USD","LU0098860793.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1186168369","title":"异动解读｜艾伯维公司盘中上涨3.01%，多家投行密集上调目标价","url":"https://stock-news.laohu8.com/highlight/detail?id=1186168369","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1186168369?lang=zh_cn&edition=full","pubTime":"2026-07-16 22:26","pubTimestamp":1784212008,"startTime":"0","endTime":"0","summary":"7月16日，艾伯维公司盘中上涨3.01%，报251.72美元/股，成交额2.3亿美元。消息面上，近期多家华尔街投行密集上调艾伯维目标价。花旗集团7月15日将目标价从230美元上调至260美元；瑞银同期上调至260美元；美国银行将目标价大幅上调至276美元，并将艾伯维列为生物制药板块首选标的；加拿大皇家银行维持\"跑赢大市\"评级，目标价上调至280美元。FactSet统计显示，艾伯维当前平均评级为\"增持\"，平均目标价266.60美元。公司将于7月31日公布第二季度财报。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"艾伯维公司盘中上涨3.01%，多家投行密集上调目标价","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ABBV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1184491056","title":"Skinmedica® 持续投资研发，深化在再生科学领域的承诺","url":"https://stock-news.laohu8.com/highlight/detail?id=1184491056","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1184491056?lang=zh_cn&edition=full","pubTime":"2026-07-14 20:06","pubTimestamp":1784030794,"startTime":"0","endTime":"0","summary":"Skinmedica®正通过持续投入研发，进一步巩固其在再生科学领域的坚定承诺。这一举措彰显了该品牌致力于推动皮肤健康与再生领域前沿科技发展的长期战略。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PJP","IE00BJT1NW94.SGD","LU1551013342.USD","LU0211328371.USD","LU0795875169.SGD","LU2023251221.USD","IE0004445239.USD","LU1430594728.SGD","LU1244550494.USD","SG9999001440.SGD","IE00B2B36J28.USD","LU1162221912.USD","LU2237443382.USD","LU0098860793.USD","LU1496350502.SGD","LU2133065610.SGD","LU1934455277.USD","LU2357627491.SGD","BK4585","IE000F7OJYX1.SGD","LU0058720904.USD","ABBV","LU1670627923.USD","LU2087621335.USD","LU0310800379.SGD","FHLC","LU0310799852.SGD","LU0985320562.USD","LU1839511570.USD","LU1934455863.HKD","LU2347655156.SGD","PPH","LU0432979614.USD","FTXH","LU0124676726.USD","LU0234572021.USD","LU0198837287.USD","LU0545039389.USD","SG9999011175.SGD","BK4533","LU0203347892.USD","LU0949170772.SGD","LU2089283258.USD","IE00B42XCP33.USD","IE00BFTCPJ56.SGD","LU1023059063.AUD","LU1244550221.USD","LU0861579265.USD","LU2237443895.HKD","BK4588","LU2089284900.SGD","SG9999003800.SGD","LU0069063385.USD","RXL","BK4559","LU0234570918.USD","LU0057025933.USD","LU0122379950.USD","LU0912757837.SGD","LU2237443622.USD","LU0256863811.USD","IE000WAW04H5.SGD","LU1496350171.SGD","IE00B3PB1722.GBP","LU1267930490.SGD","LU1037948897.HKD","LU1057294990.SGD","LU1244550577.SGD","LU1732799900.SGD","IE00BGHQF631.EUR","LU0868494708.USD","LU2129689514.USD","LU0868494617.USD","LU0128525929.USD","IYH","LU0965508806.USD","LU1074936037.SGD","LU0820561818.USD","LU1934455194.USD","IE000BZT7R73.USD","LU1291159041.SGD","BK4534","BK4566","LU2129689605.HKD","SG9999015978.USD","LU1989771016.USD","LU0320765646.SGD","LU2237443978.SGD","BK4139","IE00BVYPNV92.GBP","LU0456855351.SGD","IE00BLSP4239.USD","LU0965509101.SGD","IE000SO60NU8.SGD","IE00BSNM7G36.USD","LU0472753341.HKD","LU0511384066.AUD","LU0795875086.SGD","IE00BJJMRZ35.SGD","LU1989772840.SGD","LU1003077747.HKD","IXJ","LU0211327993.USD","LU0859254822.USD","LU0289739699.SGD","IE00BDGV0183.EUR","XLV","BK4581","LU1732800096.USD","IE0002141913.USD","LU1093756325.SGD","LU1670628061.USD","SG9999015952.SGD","LU1929549753.HKD","IE0002270589.USD","LU0417517546.SGD","SG9999015986.USD","IE00B19Z3B42.SGD","LU0823416689.USD","LU0882574055.USD","LU0203345920.USD","LU2237443465.HKD","IE00B19Z3581.USD","LU0289961442.SGD","LU0965509010.AUD","LU1551013425.SGD","LU0114720955.EUR","LU0708994859.HKD","LU0289739343.SGD","IE00BBT3K403.USD","IE00BVYPNW00.USD","IE00B4R5TH58.HKD","BK4550","LU1267930573.SGD","LU0738911758.USD","LU0029864427.USD","LU1989772923.USD","LU0553294199.USD","LU2468319806.SGD","LU0256863902.USD","LU2089984988.USD","LU0942090050.USD","LU2112291526.USD","LU0689626769.HKD","AGNG","LU0158827948.USD","LU1585245621.USD","IE00BLSP4452.SGD","VHT","LU0820561909.HKD","IE000MB6IJN5.SGD","SG9999015945.SGD","IE0000B7K699.USD","LU1061106388.HKD","JDOC","LU0943347566.SGD","IE0009355771.USD","LU2129689431.USD","MEDX","LU1983299246.USD","LU0689472784.USD","IE00BN8TJ469.HKD","LU0170899867.USD","LU0965509283.SGD","LU1037948541.HKD","LU1093756168.USD","LU1718418525.SGD","LU2237443549.SGD","LU0661504455.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1166898621","title":"艾伯维公司2026年第二季度计入2.91亿美元购买IPR&D费用，影响GAAP及调整后稀释每股收益0.17美元——SEC文件披露","url":"https://stock-news.laohu8.com/highlight/detail?id=1166898621","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1166898621?lang=zh_cn&edition=full","pubTime":"2026-07-07 04:13","pubTimestamp":1783368797,"startTime":"0","endTime":"0","summary":"根据提交给美国证券交易委员会的文件，艾伯维公司在2026年第二季度业绩中计入了高达2.91亿美元的“购买无形资产研发”费用。此项一次性支出对公司的财务指标产生了显著影响，具体表现为：按美国通用会计准则计算的稀释每股收益以及调整后的稀释每股收益均因此减少了0.17美元。购买IPR&D费用通常与收购交易相关，指为获取尚处研发阶段、尚未商业化的无形资产而支付的款项。投资者在评估公司核心运营业绩时，需关注此类调整项的影响。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1244550577.SGD","XLV","LU0868494708.USD","LU1244550494.USD","LU1023059063.AUD","IE00B19Z3B42.SGD","LU1934455194.USD","LU2023251221.USD","LU2133065610.SGD","LU1057294990.SGD","LU2237443978.SGD","LU2089284900.SGD","LU0795875169.SGD","LU0029864427.USD","LU0882574055.USD","LU1291159041.SGD","LU0203347892.USD","LU1037948541.HKD","RXL","BK4588","LU0942090050.USD","IE00BSNM7G36.USD","LU0211327993.USD","LU2347655156.SGD","LU0820561818.USD","IE00BDGV0183.EUR","SG9999001440.SGD","LU1929549753.HKD","LU0124676726.USD","SG9999015945.SGD","LU0069063385.USD","VHT","LU0472753341.HKD","LU1430594728.SGD","LU1551013425.SGD","LU1093756168.USD","LU0661504455.SGD","LU0965509283.SGD","LU0553294199.USD","LU0943347566.SGD","LU0198837287.USD","LU0708994859.HKD","LU1267930490.SGD","LU0234572021.USD","BK4550","BK4566","LU2089984988.USD","LU2237443622.USD","LU0456855351.SGD","LU0114720955.EUR","LU1585245621.USD","FHLC","LU1093756325.SGD","IE00BLSP4239.USD","LU0289739699.SGD","LU1037948897.HKD","IE0009355771.USD","IE00B2B36J28.USD","LU0417517546.SGD","LU0158827948.USD","BK4533","LU2087621335.USD","IE000BZT7R73.USD","LU0823416689.USD","LU0912757837.SGD","LU1670627923.USD","LU1989772840.SGD","IE00BVYPNW00.USD","LU0689626769.HKD","PPH","IE00BJT1NW94.SGD","LU2357627491.SGD","LU0289961442.SGD","BK4559","LU0256863902.USD","LU1983299246.USD","IE00BFTCPJ56.SGD","LU1718418525.SGD","LU1989772923.USD","LU2129689514.USD","SG9999015986.USD","LU0058720904.USD","LU0985320562.USD","LU0432979614.USD","LU0310800379.SGD","LU0128525929.USD","LU2237443382.USD","LU0289739343.SGD","IE000F7OJYX1.SGD","IE00B42XCP33.USD","LU0859254822.USD","MEDX","IE00BGHQF631.EUR","LU2089283258.USD","LU0057025933.USD","LU0795875086.SGD","LU1244550221.USD","BK4139","FTXH","IE000WAW04H5.SGD","IE00BN8TJ469.HKD","LU0256863811.USD","IE00B3PB1722.GBP","JDOC","IE00BBT3K403.USD","LU0861579265.USD","IE0002141913.USD","IE00B19Z3581.USD","IYH","LU1732799900.SGD","LU0965509010.AUD","IE00B4R5TH58.HKD","LU1934455863.HKD","LU1989771016.USD","LU1551013342.USD","LU2468319806.SGD","AGNG","LU0098860793.USD","SG9999003800.SGD","BK4585","IE0000B7K699.USD","LU0211328371.USD","IE0002270589.USD","LU0511384066.AUD","LU0234570918.USD","LU0203345920.USD","IE000SO60NU8.SGD","LU1670628061.USD","LU0738911758.USD","LU2237443895.HKD","LU2112291526.USD","LU0170899867.USD","LU1162221912.USD","IXJ","LU0545039389.USD","LU0820561909.HKD","LU1496350171.SGD","LU1732800096.USD","LU0965509101.SGD","LU1839511570.USD","LU2237443549.SGD","PJP","LU1074936037.SGD","IE00BVYPNV92.GBP","IE000MB6IJN5.SGD","BK4581","SG9999011175.SGD","LU2237443465.HKD","IE0004445239.USD","LU0949170772.SGD","LU1003077747.HKD","ABBV","LU0689472784.USD","LU1267930573.SGD","LU1934455277.USD","LU0868494617.USD","LU0965508806.USD","IE00BJJMRZ35.SGD","LU1061106388.HKD","LU0310799852.SGD","LU0122379950.USD","SG9999015978.USD","LU0320765646.SGD","LU2129689605.HKD","LU2129689431.USD","LU1496350502.SGD","BK4534","SG9999015952.SGD","IE00BLSP4452.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1135554237","title":"艾伯维宣布Tepkinly®（epcoritamab）联合来那度胺和利妥昔单抗获欧盟委员会批准用于治疗复发或难治性滤泡性淋巴瘤","url":"https://stock-news.laohu8.com/highlight/detail?id=1135554237","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1135554237?lang=zh_cn&edition=full","pubTime":"2026-07-07 01:45","pubTimestamp":1783359934,"startTime":"0","endTime":"0","summary":"艾伯维公司宣布，其药物Tepkinly®（epcoritamab）与来那度胺及利妥昔单抗的联合治疗方案，已获得欧盟委员会批准，用于治疗复发或难治性滤泡性淋巴瘤患者。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE0009355771.USD","PJP","IE00B3PB1722.GBP","LU0289739343.SGD","LU0965509010.AUD","IE00BVYPNV92.GBP","LU0211328371.USD","IE00B2B36J28.USD","LU1670628061.USD","IE000SO60NU8.SGD","LU0859254822.USD","LU0058720904.USD","IE00BN8TJ469.HKD","LU2237443895.HKD","LU0158827948.USD","IXJ","IE00B4R5TH58.HKD","IE0002141913.USD","IE0004445239.USD","IE000BZT7R73.USD","LU1670627923.USD","LU0868494617.USD","SG9999015986.USD","LU0456855351.SGD","IE00BSNM7G36.USD","LU0203345920.USD","LU0795875169.SGD","LU1732800096.USD","LU2023251221.USD","IE0000B7K699.USD","LU1074936037.SGD","LU0256863811.USD","LU1983299246.USD","LU1023059063.AUD","IE00BJT1NW94.SGD","LU1989772840.SGD","SG9999001440.SGD","LU0256863902.USD","LU0122379950.USD","LU2237443465.HKD","XLV","LU2237443549.SGD","LU2112291526.USD","LU1934455277.USD","LU0320765646.SGD","LU2129689431.USD","BK4533","LU1291159041.SGD","BK4566","LU2089284900.SGD","LU0203347892.USD","IE00BLSP4452.SGD","LU0738911758.USD","LU0965509283.SGD","IYH","LU0823416689.USD","LU1037948897.HKD","LU0949170772.SGD","LU0868494708.USD","LU0098860793.USD","LU1057294990.SGD","LU0310799852.SGD","LU0965509101.SGD","IE00B19Z3581.USD","LU0942090050.USD","LU1093756168.USD","IE00BBT3K403.USD","IE00BDGV0183.EUR","LU0069063385.USD","LU0661504455.SGD","LU2129689605.HKD","LU2089283258.USD","LU0029864427.USD","MEDX","LU0114720955.EUR","IE00BJJMRZ35.SGD","LU1732799900.SGD","LU0170899867.USD","LU1989772923.USD","LU1551013425.SGD","LU1839511570.USD","LU1244550221.USD","LU1934455863.HKD","FHLC","BK4588","LU0689626769.HKD","LU2133065610.SGD","LU1496350502.SGD","LU1061106388.HKD","SG9999015945.SGD","SG9999015952.SGD","LU0128525929.USD","LU0310800379.SGD","LU1496350171.SGD","LU0211327993.USD","LU0795875086.SGD","LU1003077747.HKD","LU1244550494.USD","LU1585245621.USD","IE00BVYPNW00.USD","LU2347655156.SGD","RXL","BK4139","LU1551013342.USD","IE00B42XCP33.USD","LU0511384066.AUD","LU0432979614.USD","LU0234572021.USD","LU1244550577.SGD","LU1989771016.USD","LU0124676726.USD","IE000F7OJYX1.SGD","LU0708994859.HKD","LU0820561818.USD","LU0057025933.USD","LU0943347566.SGD","LU0198837287.USD","LU0985320562.USD","LU0545039389.USD","LU1430594728.SGD","LU1093756325.SGD","AGNG","IE000MB6IJN5.SGD","LU1162221912.USD","LU1267930490.SGD","BK4534","LU0417517546.SGD","BK4559","LU0234570918.USD","LU2237443978.SGD","SG9999011175.SGD","PPH","IE000WAW04H5.SGD","LU1929549753.HKD","LU0820561909.HKD","LU0912757837.SGD","FTXH","LU0965508806.USD","LU2468319806.SGD","BK4550","LU2089984988.USD","ABBV","BK4581","LU0882574055.USD","BK4585","IE00BGHQF631.EUR","LU2237443382.USD","IE00B19Z3B42.SGD","VHT","LU0289739699.SGD","JDOC","LU0472753341.HKD","LU2129689514.USD","LU1037948541.HKD","LU2087621335.USD","SG9999003800.SGD","LU1718418525.SGD","LU1934455194.USD","LU2357627491.SGD","LU0861579265.USD","LU0689472784.USD","LU0553294199.USD","IE00BLSP4239.USD","LU0289961442.SGD","LU2237443622.USD","LU1267930573.SGD","IE0002270589.USD","SG9999015978.USD","IE00BFTCPJ56.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1181578824","title":"Genmab宣布Epcoritamab联合来那度胺三期试验取得积极成果","url":"https://stock-news.laohu8.com/highlight/detail?id=1181578824","media":"投资观察","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1181578824?lang=zh_cn&edition=full","pubTime":"2026-07-06 15:17","pubTimestamp":1783322279,"startTime":"0","endTime":"0","summary":"Genmab A/S公布了一项三期临床试验的积极结果，该试验评估了Epcoritamab联合来那度胺在复发/难治性弥漫性大B细胞淋巴瘤患者中的疗效。数据显示，该联合疗法在无进展生存期方面取得了统计学上的显著改善。\n这项名为EPCORE DLBCL-4的试验达到了其主要终点，结果显示，与对照组相比，该治疗方案可将疾病进展或死亡的风险降低高达60%。此外，Epcoritamab联合来那度胺展现出了一致的安全性特征。\nGenmab及其合作伙伴艾伯维公司计划就EPCORE DLBCL-4的试验结果与监管机构进行沟通。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0417517546.SGD","LU0738911758.USD","LU2357627491.SGD","LU0795875086.SGD","LU1670627923.USD","LU1430594728.SGD","LU0823416689.USD","BK4550","LU0057025933.USD","IE00BGHQF631.EUR","LU1244550494.USD","LU1934455277.USD","LU2089284900.SGD","LU0965509101.SGD","SG9999015986.USD","LU0122379950.USD","LU0234572021.USD","LU0820561909.HKD","LU0943347566.SGD","LU0289739343.SGD","LU1585245621.USD","IE00BBT3K403.USD","LU0965508806.USD","LU0170899867.USD","IE000WAW04H5.SGD","IE0000B7K699.USD","LU1037948541.HKD","LU2347655156.SGD","LU0198837287.USD","LU0708994859.HKD","LU1061106388.HKD","IXJ","IE000MB6IJN5.SGD","LU0689626769.HKD","IE00BVYPNW00.USD","LU0158827948.USD","IE0009355771.USD","IE00B19Z3B42.SGD","VHT","LU0661504455.SGD","LU1496350502.SGD","LU0942090050.USD","MEDX","LU0949170772.SGD","LU0124676726.USD","FTXH","LU1074936037.SGD","BK4588","IE000SO60NU8.SGD","IE00BSNM7G36.USD","LU0310800379.SGD","LU0553294199.USD","LU1989772840.SGD","IE0002141913.USD","LU2089283258.USD","IE00B2B36J28.USD","LU2133065610.SGD","IE00B3PB1722.GBP","LU0234570918.USD","LU0211327993.USD","LU0795875169.SGD","LU0965509010.AUD","LU0256863902.USD","LU1732799900.SGD","LU1934455194.USD","LU2112291526.USD","IE000BZT7R73.USD","BK4139","LU2468319806.SGD","LU0320765646.SGD","LU1244550577.SGD","BK4533","LU0289961442.SGD","SG9999015978.USD","FHLC","IE00BLSP4452.SGD","LU2237443465.HKD","LU0882574055.USD","RXL","LU0859254822.USD","LU0058720904.USD","LU2129689431.USD","LU1670628061.USD","IE0002270589.USD","LU2237443895.HKD","LU1093756168.USD","LU1244550221.USD","LU0861579265.USD","IE00BVYPNV92.GBP","IE00BJJMRZ35.SGD","LU1934455863.HKD","IE00BJT1NW94.SGD","IE00BFTCPJ56.SGD","JDOC","LU0985320562.USD","LU2237443382.USD","LU0472753341.HKD","LU0128525929.USD","LU1496350171.SGD","ABBV","LU1929549753.HKD","LU0912757837.SGD","LU0868494617.USD","LU1989771016.USD","IE00B19Z3581.USD","LU1093756325.SGD","LU0289739699.SGD","LU2237443978.SGD","LU1291159041.SGD","SG9999001440.SGD","XLV","IE0004445239.USD","IE00BN8TJ469.HKD","LU1162221912.USD","PJP","IE00BLSP4239.USD","SG9999003800.SGD","LU2237443622.USD","LU1267930490.SGD","LU0868494708.USD","LU0203347892.USD","LU1983299246.USD","LU1023059063.AUD","LU2087621335.USD","LU2237443549.SGD","LU1718418525.SGD","BK4534","PPH","SG9999015952.SGD","BK4559","LU1003077747.HKD","BK4581","LU1551013425.SGD","IE00B4R5TH58.HKD","LU1267930573.SGD","LU1057294990.SGD","BK4566","LU0511384066.AUD","LU2129689605.HKD","LU1037948897.HKD","LU0098860793.USD","IE00BDGV0183.EUR","LU0965509283.SGD","LU0114720955.EUR","LU0069063385.USD","SG9999015945.SGD","LU0432979614.USD","LU2089984988.USD","SG9999011175.SGD","AGNG","LU1839511570.USD","LU0689472784.USD","IE00B42XCP33.USD","LU1732800096.USD","LU2023251221.USD","LU2129689514.USD","LU1551013342.USD","IYH","LU0820561818.USD","LU1989772923.USD","LU0256863811.USD","LU0203345920.USD","LU0029864427.USD","IE000F7OJYX1.SGD","LU0310799852.SGD","LU0211328371.USD","LU0545039389.USD","LU0456855351.SGD","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1163891833","title":"异动解读｜艾伯维公司盘中上涨3.01%，多项产品获批及积极临床数据持续催化","url":"https://stock-news.laohu8.com/highlight/detail?id=1163891833","media":"行情直击","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1163891833?lang=zh_cn&edition=full","pubTime":"2026-07-02 22:53","pubTimestamp":1783003988,"startTime":"0","endTime":"0","summary":"7月2日，艾伯维公司盘中上涨3.01%，报259.325美元/股，成交额2.19亿美元。消息面上，公司近期利好密集释放。6月30日，艾伯维宣布Epcoritamab联合来那度胺在复发或难治性弥漫性大B细胞淋巴瘤患者中取得积极三期试验结果；同期Rinvoq获欧盟CHMP积极意见，拟用于治疗重度斑秃及非节段型白癜风。叠加Skyrizi儿科适应症获欧盟批准、Maviret急性丙肝适应症获批等多项监管进展，公司产品管线价值获市场重新定价。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ABBV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647017534","title":"美国众议院委员会就中国药物临床试验展开调查后，默沙东、艾伯维股价盘前下跌。默克股价下跌1.2%，艾伯维股价下跌1%。","url":"https://stock-news.laohu8.com/highlight/detail?id=2647017534","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2647017534?lang=zh_cn&edition=full","pubTime":"2026-06-30 18:07","pubTimestamp":1782814066,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["IE00BBT3K403.USD","LU1035773651.USD","IE00B19Z3B42.SGD","LU0417517546.SGD","LU1066051811.HKD","LU1917777945.USD","LU1934455194.USD","LU1670627923.USD","LU0265550946.USD","LU2129689514.USD","IE000SO60NU8.SGD","LU0256863902.USD","LU0689626769.HKD","LU1162221912.USD","IE00BGHQF631.EUR","SG9999014575.USD","LU0545039389.USD","SG9999015952.SGD","LU0070302665.USD","MRK","LU2468319806.SGD","LU2087621335.USD","LU1061106388.HKD","BK4516","BK4559","LU0965509010.AUD","LU1496350502.SGD","LU1430594728.SGD","LU1244550221.USD","LU0203347892.USD","LU1983299246.USD","LU1934455863.HKD","SG9999001176.USD","LU2461242641.AUD","IE00BLSP4452.SGD","LU2491050071.SGD","SG9999014567.USD","LU0320765646.SGD","LU1551013425.SGD","LU0472753341.HKD","LU0058720904.USD","LU0965509101.SGD","IE00BVYPNV92.GBP","LU1974910355.USD","LU1093756168.USD","IE00BJT1NW94.SGD","IE00BLSP4239.USD","LU1941712348.USD","SG9999011175.SGD","LU1066051225.USD","LU0965509283.SGD","LU1244550494.USD","LU0965508806.USD","ABBV","LU0861579265.USD","IE00BFTCPJ56.SGD","IE0000B7K699.USD","LU0949170772.SGD","SG9999001440.SGD","LU0882574055.USD","LU2089984988.USD","LU0130102774.USD","LU1057294990.SGD","LU1732799900.SGD","LU2491049909.HKD","LU0289961442.SGD","SG9999003800.SGD","LU0980610538.SGD","LU2023251221.USD","LU0029864427.USD","LU2361045086.USD","LU2112291526.USD","LU1941712264.USD","LU1037948541.HKD","LU0211328371.USD","LU0128525929.USD","LU1989772923.USD","BK4139","LU1670628061.USD","LU0069063385.USD","LU0859254822.USD","LU1244550577.SGD","IE00B19Z3581.USD","SG9999015358.SGD","LU0868494708.USD","LU1732800096.USD","LU2106854487.HKD","LU0289739699.SGD","BK4585","LU1291159041.SGD","LU2129689605.HKD","LU1718418525.SGD","IE00B3PB1722.GBP","IE00BN8TJ469.HKD","LU0943347566.SGD","BK4581","IE000MB6IJN5.SGD","LU1074936037.SGD","LU2125909247.SGD","LU0106261372.USD","LU2133065610.SGD","LU0238689110.USD","IE00B42XCP33.USD","LU0661504455.SGD","SG9999015986.USD","LU1267930573.SGD","LU0265550359.USD","LU2433249047.HKD","LU0432979614.USD","SG9999002224.SGD","IE000M9KFDE8.USD","LU2347655156.SGD","LU0122379950.USD","LU1003077747.HKD","LU1585245621.USD","IE00BVYPNW00.USD","LU0689472784.USD","LU0511384066.AUD","LU0795875169.SGD","SGXZ57979304.SGD","LU2089284900.SGD","LU0310800379.SGD","LU1989772840.SGD","IE00B2B36J28.USD","LU0820561909.HKD","LU2237443382.USD","BK4534","LU1066053197.SGD","LU1839511570.USD","SG9999002232.USD","LU1201861249.SGD","LU0553294199.USD","SG9999015341.SGD","LU1023059063.AUD","LU0098860793.USD","BK4566","LU0006306889.USD","LU0320765489.SGD","LU1116320901.HKD","LU2361044865.SGD","LU1934455277.USD","LU0170899867.USD","LU1929549753.HKD","IE00B1BXHZ80.USD","LU0211327993.USD","LU0868494617.USD","BK4588","LU2089283258.USD","LU0057025933.USD","LU0124676726.USD","IE00B4R5TH58.HKD","SG9999001176.SGD","LU0289739343.SGD","LU0985320562.USD","LU1069347547.HKD","LU2125909593.SGD","LU0198837287.USD","LU2237443549.SGD","LU1699723380.USD","SG9999015945.SGD","LU1037948897.HKD","LU1093756325.SGD","LU2237443622.USD","LU0942090050.USD","LU2023250504.SGD","LU0158827948.USD","LU0456855351.SGD","LU1066051498.USD","LU0823416689.USD","LU2023250843.SGD","LU0738911758.USD","LU1116320737.USD","LU0795875086.SGD","LU2357627491.SGD","LU1496350171.SGD","LU0114720955.EUR","IE0002270589.USD","LU0266013472.USD","LU0648001328.SGD","IE000F7OJYX1.SGD","LU1571399168.USD","LU0820561818.USD","LU2129689431.USD","LU2324357040.USD","SG9999014542.SGD","IE0004445239.USD","LU2361044949.HKD","LU2491050154.USD","LU0234570918.USD","LU2237443465.HKD","LU1551013342.USD","LU1989771016.USD","IE00BSNM7G36.USD","IE000BZT7R73.USD","LU2237443978.SGD","LU1923622614.USD","LU0208291251.USD","LU0310799852.SGD","LU2237443895.HKD","SG9999015978.USD","IE00BJJMRZ35.SGD","IE00BDGV0183.EUR","LU2360032135.SGD","LU0234572021.USD","LU0477156953.USD","BK4550","BK4533","LU0203345920.USD","SG9999014559.SGD","IE000WAW04H5.SGD","LU0256863811.USD","IE0009355771.USD","LU1267930490.SGD","SG9999013999.USD","LU0211331839.USD","BK4007","LU2125154778.USD","LU2125154935.USD","IE0002141913.USD","LU0708994859.HKD","LU0912757837.SGD","LU0130517989.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1197525623","title":"独家：美国议员发函要求获取近十年数百项试验文件，含数据保护流程","url":"https://stock-news.laohu8.com/highlight/detail?id=1197525623","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1197525623?lang=zh_cn&edition=full","pubTime":"2026-06-30 18:03","pubTimestamp":1782813780,"startTime":"0","endTime":"0","summary":"美国国会议员已发出信函，要求相关方面提供过去约十年间进行的数百项临床试验的详细文件，其中特别要求包含与患者数据保护流程相关的信息。此举旨在对制药行业的临床试验操作，尤其是数据安全与隐私保护环节，进行更深入的审查与监督。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0553294199.USD","LU2461242641.AUD","LU1983299246.USD","SG9999015986.USD","LU0211328371.USD","LU0170899867.USD","IE000BZT7R73.USD","IE00B42XCP33.USD","IE00BJT1NW94.SGD","LU1699723380.USD","LU0511384066.AUD","BK4534","LU1571399168.USD","LU2133065610.SGD","LU0689472784.USD","LU2125154778.USD","SG9999014575.USD","IE00B3PB1722.GBP","LU0868494617.USD","LU0795875086.SGD","LU1162221912.USD","LU2125909247.SGD","LU2125154935.USD","BK4559","LU0203345920.USD","IE00BGHQF631.EUR","LU0265550946.USD","SG9999015358.SGD","BK4566","BK4007","IE00BLSP4452.SGD","LU1116320737.USD","LU0980610538.SGD","LU1093756325.SGD","LU1934455194.USD","IE0004445239.USD","LU2112291526.USD","LU1267930573.SGD","LU0985320562.USD","LU1430594728.SGD","SG9999001176.SGD","LU0124676726.USD","LU0289961442.SGD","LU0795875169.SGD","LU2237443382.USD","LU0320765646.SGD","LU0708994859.HKD","LU2357627491.SGD","LU0289739343.SGD","IE00BN8TJ469.HKD","LU0868494708.USD","LU1732799900.SGD","SG9999001440.SGD","LU1116320901.HKD","LU0310799852.SGD","LU0859254822.USD","LU1585245621.USD","LU2347655156.SGD","LU1267930490.SGD","LU0106261372.USD","LU1732800096.USD","IE000F7OJYX1.SGD","LU0417517546.SGD","LU0203347892.USD","LU0234570918.USD","LU0545039389.USD","LU1934455277.USD","LU2361044949.HKD","IE00BVYPNV92.GBP","LU1037948541.HKD","LU1069347547.HKD","LU0432979614.USD","LU1718418525.SGD","LU0861579265.USD","LU2491049909.HKD","SG9999014542.SGD","LU0057025933.USD","LU1066051498.USD","LU1941712264.USD","LU0965509010.AUD","LU2360032135.SGD","LU0943347566.SGD","LU0238689110.USD","SG9999014559.SGD","LU1066053197.SGD","LU2433249047.HKD","LU0310800379.SGD","LU0965509101.SGD","IE0000B7K699.USD","LU1929549753.HKD","LU0882574055.USD","LU0456855351.SGD","SG9999015952.SGD","LU0648001328.SGD","LU1037948897.HKD","IE00B1BXHZ80.USD","LU0122379950.USD","LU0070302665.USD","IE0002141913.USD","LU0069063385.USD","IE00BLSP4239.USD","LU2468319806.SGD","LU1023059063.AUD","LU2129689514.USD","LU0029864427.USD","LU0738911758.USD","LU1923622614.USD","IE00B2B36J28.USD","SG9999002224.SGD","IE000SO60NU8.SGD","LU0234572021.USD","IE000M9KFDE8.USD","LU0477156953.USD","LU1066051811.HKD","LU2129689605.HKD","LU0130517989.USD","LU0661504455.SGD","LU1989771016.USD","IE00BFTCPJ56.SGD","LU2089283258.USD","LU0208291251.USD","LU1201861249.SGD","LU2361045086.USD","SG9999013999.USD","LU1551013342.USD","LU2089284900.SGD","LU1670627923.USD","SG9999003800.SGD","IE00B19Z3B42.SGD","SG9999011175.SGD","LU1974910355.USD","LU0098860793.USD","MRK","SG9999002232.USD","SG9999001176.USD","SG9999014567.USD","LU1934455863.HKD","LU1035773651.USD","IE00BJJMRZ35.SGD","BK4550","IE0002270589.USD","LU1244550577.SGD","LU1291159041.SGD","IE00B4R5TH58.HKD","LU0265550359.USD","LU0912757837.SGD","LU1093756168.USD","LU1244550221.USD","SGXZ57979304.SGD","LU1074936037.SGD","IE0009355771.USD","LU2237443549.SGD","LU1989772840.SGD","LU2087621335.USD","LU2237443465.HKD","LU0211331839.USD","IE00BDGV0183.EUR","LU0198837287.USD","LU1066051225.USD","LU1989772923.USD","LU0965509283.SGD","LU0289739699.SGD","LU0006306889.USD","LU1061106388.HKD","LU2237443978.SGD","LU0114720955.EUR","ABBV","SG9999015978.USD","LU1941712348.USD","BK4581","IE00BSNM7G36.USD","LU2237443622.USD","LU1057294990.SGD","LU1839511570.USD","LU0211327993.USD","LU0256863811.USD","IE00BBT3K403.USD","LU0130102774.USD","BK4585","IE000WAW04H5.SGD","LU0820561909.HKD","LU0256863902.USD","SG9999015945.SGD","LU0158827948.USD","BK4533","LU1496350502.SGD","LU0949170772.SGD","LU2129689431.USD","LU0689626769.HKD","SG9999015341.SGD","LU1551013425.SGD","LU0472753341.HKD","LU1003077747.HKD","BK4516","BK4139","LU1670628061.USD","LU2106854487.HKD","LU2324357040.USD","LU0942090050.USD","LU2237443895.HKD","LU2491050071.SGD","LU0128525929.USD","LU2023250843.SGD","LU2023251221.USD","LU2491050154.USD","BK4588","LU0266013472.USD","LU0820561818.USD","IE000MB6IJN5.SGD","LU2125909593.SGD","LU0823416689.USD","IE00B19Z3581.USD","LU1244550494.USD","LU2089984988.USD","LU1917777945.USD","LU1496350171.SGD","IE00BVYPNW00.USD","LU0058720904.USD","LU2361044865.SGD","LU0965508806.USD","LU0320765489.SGD","LU2023250504.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1110159985","title":"艾伯维宣布Epcoritamab联合来那度胺在复发或难治性弥漫性大B细胞淋巴瘤患者中取得积极三期试验结果","url":"https://stock-news.laohu8.com/highlight/detail?id=1110159985","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1110159985?lang=zh_cn&edition=full","pubTime":"2026-06-30 04:53","pubTimestamp":1782766394,"startTime":"0","endTime":"0","summary":"艾伯维公司宣布，其药物Epcoritamab联合来那度胺，在治疗复发或难治性弥漫性大B细胞淋巴瘤患者的三期临床试验中，取得了积极成果。这一关键性研究的正面数据，为这种侵袭性淋巴瘤患者带来了新的治疗希望。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0234572021.USD","IE0002141913.USD","LU0289961442.SGD","LU0511384066.AUD","LU0942090050.USD","LU1839511570.USD","LU0859254822.USD","LU2129689605.HKD","LU0820561909.HKD","LU2089984988.USD","SG9999001440.SGD","LU0689626769.HKD","LU1551013425.SGD","LU0128525929.USD","LU1267930573.SGD","LU0708994859.HKD","LU0553294199.USD","LU1551013342.USD","LU2129689514.USD","LU2357627491.SGD","LU1061106388.HKD","LU1291159041.SGD","LU0943347566.SGD","IE00BLSP4452.SGD","LU1496350502.SGD","LU0289739343.SGD","LU0949170772.SGD","LU1496350171.SGD","IE00B3PB1722.GBP","LU0256863811.USD","LU1162221912.USD","LU1983299246.USD","IE000MB6IJN5.SGD","LU2023251221.USD","IE0002270589.USD","LU2237443382.USD","SG9999015952.SGD","BK4559","LU1244550221.USD","SG9999015978.USD","LU2129689431.USD","LU1057294990.SGD","LU2237443622.USD","LU0882574055.USD","LU0158827948.USD","BK4139","LU0289739699.SGD","LU0868494708.USD","LU1037948541.HKD","IE00B19Z3581.USD","LU0472753341.HKD","LU2089284900.SGD","LU1934455194.USD","LU2347655156.SGD","BK4585","IE00BVYPNV92.GBP","LU0198837287.USD","LU0689472784.USD","LU1244550577.SGD","IE00BLSP4239.USD","IE00BDGV0183.EUR","LU1934455863.HKD","IE0004445239.USD","IE000WAW04H5.SGD","IE00BJJMRZ35.SGD","BK4588","SG9999015986.USD","IE00BBT3K403.USD","IE00B19Z3B42.SGD","LU0029864427.USD","LU0058720904.USD","LU1732799900.SGD","LU1989772840.SGD","LU2089283258.USD","LU2468319806.SGD","SG9999003800.SGD","LU0203345920.USD","LU0234570918.USD","LU1267930490.SGD","LU2087621335.USD","LU0069063385.USD","LU0965509101.SGD","IE00BVYPNW00.USD","LU0823416689.USD","IE00B2B36J28.USD","LU0820561818.USD","LU0965508806.USD","LU1003077747.HKD","LU2133065610.SGD","LU1430594728.SGD","LU0985320562.USD","LU1732800096.USD","LU0114720955.EUR","IE00B42XCP33.USD","LU1093756168.USD","LU0320765646.SGD","BK4581","LU0456855351.SGD","LU1670627923.USD","LU0965509010.AUD","IE000SO60NU8.SGD","LU0545039389.USD","LU0310799852.SGD","IE000F7OJYX1.SGD","LU1074936037.SGD","IE0000B7K699.USD","LU1037948897.HKD","LU1023059063.AUD","LU1989771016.USD","LU0170899867.USD","SG9999011175.SGD","LU1929549753.HKD","BK4534","ABBV","IE00BFTCPJ56.SGD","LU1585245621.USD","IE0009355771.USD","LU0432979614.USD","LU0203347892.USD","LU2237443549.SGD","LU2237443978.SGD","BK4533","IE00BJT1NW94.SGD","SG9999015945.SGD","LU0310800379.SGD","LU0795875086.SGD","LU1934455277.USD","LU0417517546.SGD","LU0124676726.USD","LU0738911758.USD","LU0211328371.USD","LU1244550494.USD","LU0868494617.USD","LU0795875169.SGD","IE00BSNM7G36.USD","LU0912757837.SGD","LU0965509283.SGD","IE00BN8TJ469.HKD","LU1670628061.USD","LU2112291526.USD","LU2237443895.HKD","BK4550","BK4566","LU0211327993.USD","LU0122379950.USD","LU1989772923.USD","LU0861579265.USD","LU0057025933.USD","LU2237443465.HKD","IE00BGHQF631.EUR","LU0098860793.USD","LU0256863902.USD","LU1093756325.SGD","LU1718418525.SGD","IE00B4R5TH58.HKD","LU0661504455.SGD","IE000BZT7R73.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1130790553","title":"艾伯维公司Rinvoq®获欧盟CHMP积极意见 用于治疗成人和青少年非节段型白癜风","url":"https://stock-news.laohu8.com/highlight/detail?id=1130790553","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1130790553?lang=zh_cn&edition=full","pubTime":"2026-06-29 15:08","pubTimestamp":1782716916,"startTime":"0","endTime":"0","summary":"艾伯维公司宣布，其药物Upadacitinib（商品名：Rinvoq®）已获得欧洲药品管理局人用药品委员会（CHMP）的积极评价，该药物拟用于治疗成人和青少年非节段型白癜风患者。这一积极意见标志着该疗法在欧盟监管审批进程中迈出了关键一步。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1989772923.USD","LU0432979614.USD","IE000WAW04H5.SGD","LU1670627923.USD","IE00BGHQF631.EUR","LU1732799900.SGD","LU0203345920.USD","LU1061106388.HKD","LU2129689431.USD","LU0310800379.SGD","IE00BVYPNV92.GBP","LU2089984988.USD","LU1496350502.SGD","LU0859254822.USD","IE0002270589.USD","IE00BVYPNW00.USD","BK4534","LU0128525929.USD","LU0029864427.USD","LU0472753341.HKD","LU1551013342.USD","LU1983299246.USD","LU1989772840.SGD","IE00B4R5TH58.HKD","IE00BSNM7G36.USD","LU2087621335.USD","LU2237443895.HKD","LU0738911758.USD","IE00BLSP4239.USD","LU0943347566.SGD","LU0198837287.USD","LU1074936037.SGD","LU1732800096.USD","LU1934455194.USD","LU1244550221.USD","LU1003077747.HKD","LU0289739343.SGD","LU2237443549.SGD","LU0289961442.SGD","LU0795875086.SGD","LU0795875169.SGD","LU1093756325.SGD","LU0124676726.USD","LU0868494617.USD","LU0965509010.AUD","LU0949170772.SGD","LU0861579265.USD","IE00BLSP4452.SGD","IE0004445239.USD","LU1267930573.SGD","LU1934455863.HKD","LU0211328371.USD","SG9999011175.SGD","LU0234572021.USD","LU0234570918.USD","SG9999015952.SGD","LU0661504455.SGD","IE00BBT3K403.USD","LU0823416689.USD","LU1718418525.SGD","LU0114720955.EUR","LU0882574055.USD","IE00B3PB1722.GBP","IE00B42XCP33.USD","LU2237443978.SGD","LU0689472784.USD","LU1244550577.SGD","SG9999003800.SGD","BK4588","SG9999015945.SGD","LU1496350171.SGD","LU2023251221.USD","SG9999001440.SGD","LU0708994859.HKD","IE00BJT1NW94.SGD","LU0069063385.USD","LU0289739699.SGD","LU0158827948.USD","LU0965508806.USD","BK4139","LU0456855351.SGD","IE0002141913.USD","BK4550","IE00BJJMRZ35.SGD","IE00BN8TJ469.HKD","LU0098860793.USD","LU2089284900.SGD","LU2237443465.HKD","IE00B2B36J28.USD","IE000SO60NU8.SGD","LU1023059063.AUD","IE000F7OJYX1.SGD","LU0122379950.USD","LU2468319806.SGD","LU1551013425.SGD","LU1267930490.SGD","LU0942090050.USD","LU1037948897.HKD","LU1934455277.USD","IE00B19Z3B42.SGD","LU1093756168.USD","LU2129689605.HKD","IE00BDGV0183.EUR","LU2112291526.USD","IE00B19Z3581.USD","LU0211327993.USD","LU0689626769.HKD","LU2237443382.USD","LU0868494708.USD","SG9999015986.USD","BK4533","LU1670628061.USD","LU0417517546.SGD","LU0320765646.SGD","LU0912757837.SGD","LU0256863811.USD","LU2089283258.USD","IE0009355771.USD","LU1057294990.SGD","LU0820561909.HKD","IE0000B7K699.USD","LU0057025933.USD","LU0310799852.SGD","LU0965509101.SGD","LU1430594728.SGD","LU0965509283.SGD","BK4581","LU1291159041.SGD","LU0985320562.USD","LU2347655156.SGD","BK4566","BK4559","SG9999015978.USD","LU1162221912.USD","LU0511384066.AUD","LU1037948541.HKD","LU1989771016.USD","LU2237443622.USD","LU2133065610.SGD","LU1929549753.HKD","LU0058720904.USD","LU0553294199.USD","IE000MB6IJN5.SGD","LU0170899867.USD","LU1839511570.USD","IE00BFTCPJ56.SGD","LU2357627491.SGD","IE000BZT7R73.USD","ABBV","LU1244550494.USD","LU2129689514.USD","LU1585245621.USD","LU0256863902.USD","LU0820561818.USD","LU0545039389.USD","LU0203347892.USD","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1143206979","title":"一周美股牛榜 | Bio-Techne上周飙涨逾22%，艾伯维公司劲升逾17%，联合大陆航空涨超15%，康宁涨超13%","url":"https://stock-news.laohu8.com/highlight/detail?id=1143206979","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1143206979?lang=zh_cn&edition=full","pubTime":"2026-06-29 10:18","pubTimestamp":1782699520,"startTime":"0","endTime":"0","summary":"默克提出每股73美元的收购要约后，Bio-Techne股价本周上涨22.5%，较该公司周三收盘价溢价24%。艾伯维斥资109亿美元收购Apogee，强化免疫学领域战略艾伯维股价本周上涨17%。联合大陆航空股价上涨，油价下跌和分析师看涨情绪提振航空股本周，联合大陆航空股价上涨15%。为了进一步提升股东价值，康宁董事会宣布派发每股0.28美元的季度股息。股息将于9月29日支付给截至8月31日登记在册的股东。","market":"us","thumbnail":"https://static.tigerbbs.com/98882962e3042a24d8295da8457c9db5","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/98882962e3042a24d8295da8457c9db5"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RVTY","TECH","GLW","IQV","CRL","UAL","GLWG","ABBV","INCY"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"1187753194","title":"异动解读｜艾伯维公司盘中上涨3.31%，109亿美元收购Apogee叠加多重产品获批持续提振","url":"https://stock-news.laohu8.com/highlight/detail?id=1187753194","media":"行情直击","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1187753194?lang=zh_cn&edition=full","pubTime":"2026-06-27 03:56","pubTimestamp":1782503815,"startTime":"0","endTime":"0","summary":"6月26日，艾伯维公司盘中上涨3.31%，报251.23美元/股，成交额22.61亿美元。消息面上，公司近日宣布以约109亿美元全现金收购Apogee Therapeutics，获取核心资产zumilokibart，UBS认为该交易估值\"充分合理\"，该药在特应性皮炎及哮喘领域具备\"超级重磅炸弹潜力\"。同时，Canaccord Genuity将目标价上调至273美元，Rothschild & Co Redburn上调至284美元，均维持买入评级。产品端，Skyrizi获欧盟批准扩展至儿童银屑病，Maviret获批用于急性丙肝，多重利好共振持续推升股价。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ABBV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1199295327","title":"异动解读｜艾伯维公司盘中上涨3.23%，109亿美元收购Apogee持续提振叠加多重利好","url":"https://stock-news.laohu8.com/highlight/detail?id=1199295327","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1199295327?lang=zh_cn&edition=full","pubTime":"2026-06-25 22:49","pubTimestamp":1782398942,"startTime":"0","endTime":"0","summary":"6月25日，艾伯维公司盘中上涨3.23%，报242.47美元/股，成交额3.75亿美元。消息面上，艾伯维近日宣布以约109亿美元全现金收购Apogee Therapeutics，获取其核心资产zumilokibart，强化免疫学管线布局。Canaccord Genuity随后将艾伯维目标价从265美元上调至273美元，维持买入评级。此外，艾伯维旗下Skyrizi获欧盟批准用于儿童银屑病、Maviret获批用于急性丙肝治疗，旗下艾尔建美学新品Boey在加拿大获批，多重产品线利好共同提振市场信心。交易预计三季度完成，反垄断风险有限。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ABBV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1136601431","title":"医美巨头证实“司美格鲁肽脸”真实存在 新上市再生医美公司欲入局分羹","url":"https://stock-news.laohu8.com/highlight/detail?id=1136601431","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1136601431?lang=zh_cn&edition=full","pubTime":"2026-06-25 21:06","pubTimestamp":1782392808,"startTime":"0","endTime":"0","summary":"医美行业巨头们已证实，由GLP-1减肥药引发的面部脂肪流失现象——“司美格鲁肽脸”——是真实存在的副作用。这一市场新动态，正为专注于再生医学的医美公司开辟出全新的竞争赛道。一家新近上市的再生医学领域参与者，已明确表示将瞄准这一快速增长的需求。市场分析指出，“司美格鲁肽脸”现象催生的不仅是新的治疗需求，更是一个潜在的交叉增长市场。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE0000B7K699.USD","IE0002270589.USD","LU0029864427.USD","LU1496350171.SGD","LU2237443622.USD","LU0689472784.USD","BK4533","IE00B19Z3581.USD","LU1244550221.USD","IE00BLSP4452.SGD","LU0861579265.USD","LU2089984988.USD","LU0158827948.USD","SG9999003800.SGD","LU2129689431.USD","LU1983299246.USD","LU1061106388.HKD","LU1929549753.HKD","LU0170899867.USD","SG9999015978.USD","LU2133065610.SGD","IE00BFTCPJ56.SGD","LU0965509283.SGD","LU0511384066.AUD","LU0708994859.HKD","LU1074936037.SGD","IE00BSNM7G36.USD","LU1732799900.SGD","LU1670627923.USD","CNXU","LU1934455194.USD","LU0417517546.SGD","LU2237443382.USD","ABBV","LU2237443895.HKD","LU0128525929.USD","LU0203345920.USD","LU0256863902.USD","IE000MB6IJN5.SGD","LU0432979614.USD","LU0965509010.AUD","LU2089283258.USD","LU0211327993.USD","LU0689626769.HKD","LU1718418525.SGD","LU0859254822.USD","LU1496350502.SGD","IE00B19Z3B42.SGD","LU2237443549.SGD","IE00B2B36J28.USD","LU0795875086.SGD","LU0203347892.USD","LU2468319806.SGD","IE00B4R5TH58.HKD","IE000SO60NU8.SGD","LU1037948541.HKD","LU0472753341.HKD","LU1267930573.SGD","LU0211328371.USD","SG9999011175.SGD","LU0289739699.SGD","LU0545039389.USD","LU1267930490.SGD","LU0234570918.USD","LU2129689605.HKD","SG9999015952.SGD","IE0004445239.USD","IE00BDGV0183.EUR","LU1244550494.USD","IE0009355771.USD","SG9999015986.USD","LU2324357040.USD","LU1989772923.USD","SG9999001440.SGD","LU1670628061.USD","LU2089284900.SGD","IE000F7OJYX1.SGD","IE0002141913.USD","LU1037948897.HKD","LU1551013425.SGD","BK4585","IE00BJT1NW94.SGD","LU0795875169.SGD","LU1244550577.SGD","IE00B3PB1722.GBP","LU0310799852.SGD","IE00BJJMRZ35.SGD","LU1989771016.USD","LU0985320562.USD","LU2357627491.SGD","IE00BVYPNV92.GBP","IE00B42XCP33.USD","LU0882574055.USD","LU1732800096.USD","LU0942090050.USD","BK4198","BK4588","SG9999015945.SGD","LU1093756325.SGD","LU2023251221.USD","LU0456855351.SGD","LU1551013342.USD","LU1430594728.SGD","LU1291159041.SGD","LU2237443978.SGD","IE000BZT7R73.USD","LU2237443465.HKD","LU0738911758.USD","LU0058720904.USD","LU0949170772.SGD","LU0943347566.SGD","LU1839511570.USD","LU0868494617.USD","LU1585245621.USD","LU1934455863.HKD","LU2347655156.SGD","LU0661504455.SGD","BK4534","LU0912757837.SGD","LU1162221912.USD","LU0820561818.USD","LU0965508806.USD","BK4559","IE00BN8TJ469.HKD","LU1989772840.SGD","LU1057294990.SGD","LU1934455277.USD","LU2087621335.USD","LU0057025933.USD","LU0820561909.HKD","LU0198837287.USD","LU2129689514.USD","IE00BVYPNW00.USD","LU0234572021.USD","LU0320765646.SGD","BK4139","LU0289961442.SGD","LU0553294199.USD","ESTA","LU0310800379.SGD","LU0868494708.USD","LU1093756168.USD","IE000WAW04H5.SGD","LU1003077747.HKD","IE00BBT3K403.USD","LU0256863811.USD","IE00BGHQF631.EUR","BK4550","BK4581","LU2112291526.USD","LU0122379950.USD","LU0069063385.USD","INMD","LU0098860793.USD","BK4082","BK4566","LU0965509101.SGD","LU0124676726.USD","LU0289739343.SGD","LU0114720955.EUR","LU1023059063.AUD","LU0823416689.USD","IE00BLSP4239.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1117059267","title":"艾伯维-爱力根美学部门将启动培训，为未来数月内Boey的商业上市做准备","url":"https://stock-news.laohu8.com/highlight/detail?id=1117059267","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1117059267?lang=zh_cn&edition=full","pubTime":"2026-06-23 20:02","pubTimestamp":1782216166,"startTime":"0","endTime":"0","summary":"艾伯维公司旗下的爱力根美学部门即将启动相关培训工作，并为新产品Boey在未来几个月内的商业上市进行筹备。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0942090050.USD","IE00BSNM7G36.USD","LU0820561909.HKD","LU0432979614.USD","LU2129689514.USD","LU2237443465.HKD","LU0158827948.USD","LU2237443978.SGD","BK4566","IE000F7OJYX1.SGD","BK4588","LU0029864427.USD","LU0234572021.USD","LU0289961442.SGD","LU1983299246.USD","BK4139","LU0198837287.USD","LU0985320562.USD","LU2237443382.USD","LU2237443895.HKD","LU1291159041.SGD","LU0868494617.USD","LU1934455277.USD","LU1934455194.USD","IE00B3PB1722.GBP","LU1732800096.USD","LU0069063385.USD","LU1989772923.USD","LU1037948541.HKD","LU1430594728.SGD","IE000SO60NU8.SGD","IE00BN8TJ469.HKD","LU2133065610.SGD","LU0868494708.USD","LU1551013342.USD","LU1057294990.SGD","IE00BFTCPJ56.SGD","IE00B2B36J28.USD","LU0545039389.USD","LU1496350502.SGD","IE00BDGV0183.EUR","LU2237443622.USD","LU1244550494.USD","LU1839511570.USD","LU0124676726.USD","LU0170899867.USD","LU0965509010.AUD","IE00B42XCP33.USD","IE00B19Z3581.USD","LU1061106388.HKD","LU2089284900.SGD","IE00BBT3K403.USD","BK4534","LU0912757837.SGD","IE0009355771.USD","IE000WAW04H5.SGD","LU0949170772.SGD","LU0211328371.USD","LU2089283258.USD","LU0823416689.USD","BK4533","LU1934455863.HKD","IE0004445239.USD","LU1989772840.SGD","IE00B4R5TH58.HKD","LU0122379950.USD","LU0114720955.EUR","IE0000B7K699.USD","LU0738911758.USD","SG9999015978.USD","LU1496350171.SGD","LU0943347566.SGD","LU0098860793.USD","IE00BLSP4239.USD","LU1551013425.SGD","LU0058720904.USD","LU0965509283.SGD","IE00BJJMRZ35.SGD","BK4585","IE00B19Z3B42.SGD","SG9999001440.SGD","LU0057025933.USD","LU2023251221.USD","LU1670627923.USD","LU0289739699.SGD","LU2129689605.HKD","SG9999003800.SGD","SG9999011175.SGD","LU1718418525.SGD","LU0211327993.USD","LU0289739343.SGD","LU1244550221.USD","IE00BJT1NW94.SGD","LU0861579265.USD","LU2112291526.USD","LU1585245621.USD","LU0511384066.AUD","LU1003077747.HKD","IE0002141913.USD","LU0456855351.SGD","LU1093756168.USD","LU0320765646.SGD","IE0002270589.USD","SG9999015986.USD","LU1037948897.HKD","LU1732799900.SGD","BK4559","LU1023059063.AUD","LU0417517546.SGD","LU0310800379.SGD","LU1244550577.SGD","LU0661504455.SGD","LU1989771016.USD","LU2129689431.USD","LU2087621335.USD","LU0256863902.USD","LU1074936037.SGD","LU0310799852.SGD","LU0689472784.USD","LU0128525929.USD","LU0472753341.HKD","LU0965509101.SGD","LU2347655156.SGD","LU2468319806.SGD","LU0859254822.USD","LU1267930490.SGD","ABBV","LU0203345920.USD","LU1162221912.USD","BK4550","IE00BLSP4452.SGD","BK4581","LU0795875086.SGD","IE00BGHQF631.EUR","LU0203347892.USD","IE000MB6IJN5.SGD","IE00BVYPNW00.USD","LU2237443549.SGD","LU0234570918.USD","LU2089984988.USD","LU1670628061.USD","LU0553294199.USD","LU1929549753.HKD","LU2357627491.SGD","LU0795875169.SGD","LU1093756325.SGD","LU0256863811.USD","SG9999015945.SGD","LU0820561818.USD","LU0882574055.USD","SG9999015952.SGD","LU1267930573.SGD","LU0965508806.USD","LU0708994859.HKD","IE00BVYPNV92.GBP","LU0689626769.HKD","IE000BZT7R73.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1143485673","title":"艾伯维宣布Maviret®获欧盟批准用于治疗急性丙型肝炎病毒感染","url":"https://stock-news.laohu8.com/highlight/detail?id=1143485673","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1143485673?lang=zh_cn&edition=full","pubTime":"2026-06-23 17:00","pubTimestamp":1782205239,"startTime":"0","endTime":"0","summary":"艾伯维公司宣布，其药物Maviret®（格卡瑞韦/哌仑他韦）已获得欧洲委员会的批准，用于治疗急性丙型肝炎病毒感染患者。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0868494708.USD","LU2023251221.USD","LU0738911758.USD","IE0002141913.USD","LU0795875169.SGD","LU1244550221.USD","LU0965509283.SGD","LU1989772923.USD","LU0320765646.SGD","LU1003077747.HKD","LU0310799852.SGD","LU1929549753.HKD","BK4588","LU1244550577.SGD","IE0004445239.USD","IE00B19Z3581.USD","IE00B2B36J28.USD","LU0098860793.USD","LU2089283258.USD","SG9999015986.USD","IE00BDGV0183.EUR","LU1093756325.SGD","LU0545039389.USD","LU0823416689.USD","IE00BSNM7G36.USD","LU2129689514.USD","BK4581","LU0203345920.USD","LU0057025933.USD","LU0432979614.USD","LU0820561909.HKD","SG9999001440.SGD","LU2237443549.SGD","IE000WAW04H5.SGD","LU1496350171.SGD","LU2087621335.USD","LU0859254822.USD","LU2129689605.HKD","IE000BZT7R73.USD","IE00B19Z3B42.SGD","LU2237443382.USD","LU0882574055.USD","LU0124676726.USD","LU0553294199.USD","LU1162221912.USD","LU2468319806.SGD","LU0234570918.USD","ABBV","LU0069063385.USD","LU0417517546.SGD","LU1732799900.SGD","LU0943347566.SGD","LU2347655156.SGD","LU0114720955.EUR","LU0861579265.USD","BK4566","LU2237443465.HKD","LU0289961442.SGD","LU1267930490.SGD","LU1551013342.USD","LU1839511570.USD","LU0868494617.USD","BK4139","IE000SO60NU8.SGD","LU0689626769.HKD","BK4559","LU0456855351.SGD","LU0472753341.HKD","LU1267930573.SGD","LU0158827948.USD","LU0511384066.AUD","IE00B4R5TH58.HKD","LU0795875086.SGD","BK4585","LU1093756168.USD","LU0689472784.USD","LU0234572021.USD","IE0002270589.USD","LU1989771016.USD","LU0708994859.HKD","LU0256863902.USD","LU1934455863.HKD","LU2237443622.USD","LU1037948897.HKD","BK4534","IE00BVYPNV92.GBP","LU1430594728.SGD","SG9999015945.SGD","LU1983299246.USD","LU0058720904.USD","LU1934455277.USD","LU1074936037.SGD","LU2089284900.SGD","LU0256863811.USD","LU2112291526.USD","LU0289739699.SGD","LU1037948541.HKD","IE0000B7K699.USD","IE00BJT1NW94.SGD","LU0198837287.USD","IE00BN8TJ469.HKD","LU0122379950.USD","LU2133065610.SGD","LU2237443978.SGD","IE000MB6IJN5.SGD","LU0912757837.SGD","LU1291159041.SGD","LU0985320562.USD","LU0289739343.SGD","IE0009355771.USD","IE00B42XCP33.USD","LU1989772840.SGD","SG9999015978.USD","IE000F7OJYX1.SGD","SG9999011175.SGD","LU1061106388.HKD","IE00BLSP4239.USD","IE00BBT3K403.USD","LU1496350502.SGD","LU0203347892.USD","LU2089984988.USD","IE00BJJMRZ35.SGD","LU2129689431.USD","BK4550","LU1057294990.SGD","IE00BGHQF631.EUR","LU1244550494.USD","LU0820561818.USD","LU0310800379.SGD","LU0029864427.USD","LU0942090050.USD","SG9999003800.SGD","SG9999015952.SGD","LU0128525929.USD","LU1718418525.SGD","LU1934455194.USD","BK4533","LU0661504455.SGD","LU0211327993.USD","LU1551013425.SGD","LU1585245621.USD","LU0965509101.SGD","IE00BLSP4452.SGD","LU0965508806.USD","LU1732800096.USD","LU2237443895.HKD","LU1023059063.AUD","LU1670628061.USD","LU0170899867.USD","LU0211328371.USD","LU0949170772.SGD","LU0965509010.AUD","IE00BVYPNW00.USD","LU2357627491.SGD","LU1670627923.USD","IE00B3PB1722.GBP","IE00BFTCPJ56.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645888902","title":"艾伯维(ABBV)免疫产品SKYRIZI获欧盟批准 扩展至儿童与青少年中重度斑块状银屑病范畴","url":"https://stock-news.laohu8.com/highlight/detail?id=2645888902","media":"金吾财讯","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2645888902?lang=zh_cn&edition=full","pubTime":"2026-06-23 16:28","pubTimestamp":1782203332,"startTime":"0","endTime":"0","summary":"该药现可用于治疗6岁及以上、适合接受系统治疗的中重度斑块状银屑病儿童和青少年患者。临床数据显示，在入组的137名儿童及青少年患者中，SKYRIZI展现出的安全性特征与此前在成年患者中观察到的高度一致，未发现任何新的安全信号。艾伯维高级副总裁兼首席科学官Roopal Thakkar博士表示，儿童斑块状银屑病具有极高的临床复杂性。","market":"sh","thumbnail":"https://static.szfiu.com/news/20250107/YTM1NDI1NzQzMjY4NQ==.png","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250107/YTM1NDI1NzQzMjY4NQ==.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"301776","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["FESXmain","LU0057025933.USD","LU0203345920.USD","IE00BLSP4239.USD","LU0511384066.AUD","LU1244550494.USD","SG9999001440.SGD","IE00B2B36J28.USD","LU0795875086.SGD","LU2237443549.SGD","LU0868494617.USD","LU0965508806.USD","LU1057294990.SGD","LU0417517546.SGD","LU1162221912.USD","LU0320765646.SGD","LU2089284900.SGD","LU0234570918.USD","ABBV","SG9999011175.SGD","BK4550","LU2089283258.USD","LU0472753341.HKD","LU2112291526.USD","LU2237443382.USD","LU0882574055.USD","LU1244550221.USD","LU2468319806.SGD","LU0949170772.SGD","LU1291159041.SGD","IE000BZT7R73.USD","LU2133065610.SGD","IE00BFTCPJ56.SGD","LU1934455277.USD","IE00B19Z3B42.SGD","IE00BLSP4452.SGD","IE00BVYPNV92.GBP","LU0942090050.USD","LU1929549753.HKD","BK4533","LU0912757837.SGD","BK4534","LU1496350171.SGD","SG9999015945.SGD","LU1023059063.AUD","LU1989771016.USD","LU0738911758.USD","IE0009355771.USD","FSXEmain","IE00BGHQF631.EUR"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.abbvie.com","stockEarnings":[{"period":"1week","weight":0.0191},{"period":"1month","weight":0.1042},{"period":"3month","weight":0.3052},{"period":"6month","weight":0.1829},{"period":"1year","weight":0.3591},{"period":"ytd","weight":0.1351}],"compareEarnings":[{"period":"1week","weight":-0.0059},{"period":"1month","weight":0.0078},{"period":"3month","weight":0.035},{"period":"6month","weight":0.0721},{"period":"1year","weight":0.1647},{"period":"ytd","weight":0.0836}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"艾伯维公司注册成立于2012年4月10日，是一家全球性的、以研究为基础的生物制药公司。Abbvie公司从事开发和销售先进的疗法，来解决一些世界上最复杂和严重的疾病。Abbvie公司的产品主要集中在慢性自身免疫性疾病领域，包括类风湿性关节炎，牛皮癣和克罗恩病，银屑病和克罗恩病;低睾酮，HIV，子宫内膜异位症;甲状腺疾病;帕金森病;和并发症的慢性肾脏疾病和囊性纤维化相关的或其他健康问题。","yearOnYearQuotes":[{"month":1,"riseRate":0.357143,"avgChangeRate":-0.019222},{"month":2,"riseRate":0.857143,"avgChangeRate":0.039081},{"month":3,"riseRate":0.714286,"avgChangeRate":0.001102},{"month":4,"riseRate":0.571429,"avgChangeRate":0.006536},{"month":5,"riseRate":0.642857,"avgChangeRate":0.004172},{"month":6,"riseRate":0.5,"avgChangeRate":0.019288},{"month":7,"riseRate":0.571429,"avgChangeRate":0.013631},{"month":8,"riseRate":0.538462,"avgChangeRate":0.007409},{"month":9,"riseRate":0.538462,"avgChangeRate":0.014941},{"month":10,"riseRate":0.615385,"avgChangeRate":0.007438},{"month":11,"riseRate":0.769231,"avgChangeRate":0.063841},{"month":12,"riseRate":0.692308,"avgChangeRate":0.025718}],"exchange":"NYSE","name":"艾伯维公司","nameEN":"AbbVie"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"艾伯维公司(ABBV)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供艾伯维公司(ABBV)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"艾伯维公司,ABBV,艾伯维公司股票,艾伯维公司股票老虎,艾伯维公司股票老虎国际,艾伯维公司行情,艾伯维公司股票行情,艾伯维公司股价,艾伯维公司股市,艾伯维公司股票价格,艾伯维公司股票交易,艾伯维公司股票购买,艾伯维公司股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"艾伯维公司(ABBV)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供艾伯维公司(ABBV)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}